Home » Stocks » VAPO

Vapotherm, Inc. (VAPO)

Stock Price: $18.72 USD -2.91 (-13.45%)
Updated May 6, 2021 4:00 PM EDT - Market closed
After-hours: $18.75 +0.03 (0.16%) May 6, 5:18 PM
Market Cap 560.49M
Revenue (ttm) 125.73M
Net Income (ttm) -51.50M
Shares Out 23.82M
EPS (ttm) -2.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 6
Last Price $18.72
Previous Close $21.63
Change ($) -2.91
Change (%) -13.45%
Day's Open 20.58
Day's Range 18.65 - 21.12
Day's Volume 577,996
52-Week Range 18.65 - 54.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Vapotherm (VAPO) delivered earnings and revenue surprises of 2.44% and 2.31%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

22 hours ago - Zacks Investment Research

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapot...

1 day ago - Business Wire

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapoth...

2 weeks ago - Business Wire

Vapotherm (VAPO) delivered earnings and revenue surprises of 10.53% and 0.82%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapot...

2 months ago - Business Wire

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapot...

2 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapot...

2 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapot...

3 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapot...

3 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)---- $VAPO--Vapotherm, Inc. (NYSE:VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its propriet...

5 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapot...

5 months ago - Business Wire

Vapotherm's Hi-VNI technology is more comfortable and safer than current technologies used to treat patients with respiratory distress. The company has seen meaningful sales increases over the past two ...

5 months ago - Seeking Alpha

Vapotherm, Inc. (VAPO) CEO Joe Army on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Vapotherm (VAPO) delivered earnings and revenue surprises of 19.67% and 26.80%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary high ...

6 months ago - Business Wire

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

MENLO PARK, Calif.--(BUSINESS WIRE)--CIBC Innovation Banking is pleased to announce a US$52 million growth capital financing with Exeter-based Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm”), a global medic...

6 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary high ...

6 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary high ...

6 months ago - Business Wire

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of Vapotherm's proprietar...

6 months ago - Business Wire

Vapotherm (VAPO) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

7 months ago - Zacks Investment Research

Vapotherm - COVID-19 Comes To The Rescue

8 months ago - Seeking Alpha

Vapotherm, Inc. (VAPO) CEO Joe Army on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc.

9 months ago - Business Wire

Vapotherm (VAPO) delivered earnings and revenue surprises of 10.26% and 20.80%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc.

9 months ago - Business Wire

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc.

9 months ago - Business Wire

The company's products are getting exposure, thanks in part to the coronavirus pandemic.

11 months ago - The Motley Fool

The company released its fiscal first-quarter results.

1 year ago - The Motley Fool

Vapotherm (VAPO) delivered earnings and revenue surprises of -17.86% and 1.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Does Vapotherm (VAPO) have what it takes to be a top stock pick for momentum investors? Let's find out.

1 year ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor Vapotherm

1 year ago - Zacks Investment Research

Oxygen therapy has emerged as a necessity for COVID-19 patients.

Other stocks mentioned: INGN, IVC
1 year ago - Zacks Investment Research

Vapotherm (VAPO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

1 year ago - Zacks Investment Research

Vapotherm, Inc. (VAPO) CEO Joe Army on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Vapotherm (VAPO) delivered earnings and revenue surprises of 16.67% and 6.64%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Vapotherm, Inc. (VAPO) CEO Joe Army on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

President & CEO of Vapotherm Inc (30-Year Financial, Insider Trades) Joseph Army (insider trades) bought 10,000 shares of VAPO on 09/04/2019 at an average price of $10 a share.

1 year ago - GuruFocus

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Other stocks mentioned: ACMR, CMCO, EQC, LRN
1 year ago - Zacks Investment Research

Vapotherm, Inc. (VAPO) CEO Joseph Army on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Vapotherm, Inc. (VAPO) CEO Joe Army on Q1 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

About VAPO

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companio... [Read more...]

Industry
Medical Devices
IPO Date
Nov 14, 2018
CEO
Joseph Army
Employees
397
Stock Exchange
NYSE
Ticker Symbol
VAPO
Full Company Profile

Financial Performance

In 2020, Vapotherm's revenue was $125.73 million, an increase of 161.38% compared to the previous year's $48.10 million. Losses were -$51.50 million, 0.87% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Vapotherm stock is "Strong Buy." The 12-month stock price forecast is 41.00, which is an increase of 119.02% from the latest price.

Price Target
$41.00
(119.02% upside)
Analyst Consensus: Strong Buy